Hematological Alterations in Patients with COVID-19

Dania María García Rodríguez, Dionis Ruiz Reyes, Madyaret Águila Carbelo, Adriel Herrero Díaz and Ileana Beatriz Quiroga López

South Health and Policy, 2025, vol. 4, 242-242

Abstract: Currently, the global population is under siege from COVID-19, a disease caused by the SARS-CoV-2 coronavirus, which has been declared a pandemic by the World Health Organization. COVID-19 usually presents with mild respiratory symptoms but is also associated with less common and somewhat delayed clinical manifestations such as thrombotic events (arterial or venous), skin inflammation, vasculitis, and the development of pulmonary fibrosis. A literature review was conducted with the aim of characterizing hematological changes in patients during COVID-19. A total of 23 bibliographic references were reviewed, including books, journals, and websites from the Scielo and Infomed platforms. It was found that the main hematological alterations caused by COVID-19 include lymphocytopenia, increased D-dimer, thrombocytopenia, platelet deficiency, and thrombosis, all of which are favored by the cytokine storm.

Date: 2025
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:dbk:southh:2025v4a140

DOI: 10.56294/shp2025242

Access Statistics for this article

More articles in South Health and Policy from AG Editor (Argentina)
Bibliographic data for series maintained by Javier Gonzalez-Argote ().